A new solid target design for the production of 89Zr and radiosynthesis of high molar activity [89Zr]Zr-DBN.
Ontology highlight
ABSTRACT: Due to the advent of various biologics like antibodies, proteins, cells, viruses, and extracellular vesicles as biomarkers for disease diagnosis, progression, and as therapeutics, there exists a need to have a simple and ready to use radiolabeling synthon to enable noninvasive imaging trafficking studies. Previously, we reported [89Zr]zirconium-p-isothiocyanatobenzyl-desferrioxamine ([89Zr]Zr-DBN) as a synthon for the radiolabeling of biologics to allow PET imaging of cell trafficking. In this study, we focused on improving the molar activity (Am) of [89Zr]Zr-DBN, by enhancing 89Zr production on a low-energy cyclotron and developing a new reverse phase HPLC method to purify [89Zr]Zr-DBN. To enhance 89Zr pro
SUBMITTER: Pandey MK
PROVIDER: S-EPMC8918403 | biostudies-literature | 2022
REPOSITORIES: biostudies-literature
ACCESS DATA